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In Brief
MAGUK loss reduces the number of
synapses containing AMPA receptors.
Levy et al. identify a synapse-specific
homeostatic program triggered by
MAGUK loss that consolidates remaining
synaptic AMPA receptors at a subset of
synapses to preserve synaptic strength.
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The mechanisms controlling synapse growth and
maintenance are of critical importance for learning
and memory. The MAGUK family of synaptic scaf-
folding proteins is abundantly expressed at glutama-
tergic central synapses, but their importance in con-
trolling the synaptic content of glutamate receptors
is poorly understood. Here, we use a chained RNAi-
mediated knockdown approach to simultaneously
remove PSD-93, PSD-95, and SAP102, the MAGUKs
previously shown tobe responsible for synaptic local-
ization of glutamate receptors. We find that MAGUKs
are specifically responsible for creating functional
synapses after initial spine formation by filling
functionally silent spines with glutamate receptors.
Removal of theMAGUKs causes a transient reduction
in AMPA receptor quantal size followed by synaptic
consolidation resulting in a normalization of quantal
sizeat the fewremaining functional synapses.Consol-
idation requires signaling through L-type calcium
channels, CaM kinase kinase, and the GluA2 AMPA
receptor subunit, akin to a homeostatic process.
INTRODUCTION
The glutamatergic synapse, consisting of a postsynaptic
specialization with clustered glutamate receptors opposite a
presynaptic terminal, is the site of fast excitatory neurotransmis-
sion in the brain. Proper formation of the postsynaptic specializa-
tion requires that glutamate receptors localize to the synapse
and associate with the complex network of signaling and scaf-
folding molecules known as the postsynaptic density (PSD).
The process of glutamate receptor trafficking and localization
has been extensively studied, and multiple lines of evidence
demonstrate that the PSD scaffolding proteins themselves play
an instructive role in regulating the localization of synaptic gluta-
mate receptors (El-Husseini et al., 2000; Schnell et al., 2002). The
primary protein family implicated in synaptic glutamate receptor
localization is the four-member membrane-associated guanylyl
kinase (MAGUK) family (Elias and Nicoll, 2007; Opazo et al.,
2012): PSD-93, PSD-95, SAP97, and SAP102.534 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.The MAGUKs are membrane-associated cytoplasmic scaf-
folding proteins that are highly enriched at the PSD and are
ideally situated to serve as a bridge between glutamate recep-
tors and cytoplasmic structural proteins, such as polymerized
actin, that form the protein backbone of the dendritic spine.
MAGUKs are anchored to the plasma membrane at postsyn-
aptic specializations primarily by N-terminal palmitoylation,
directly and indirectly bind glutamate receptors via PDZ binding
domains, and link these receptors to the cytoplasmic protein
scaffold with C-terminal SH3 and GK domains (Kim and Sheng,
2004). Germline knockout of single MAGUKs has little or no ef-
fect, but these results are confounded by compensation within
the MAGUK family (Elias et al., 2006). RNAi-mediated knock-
down, an acute manipulation, does not suffer from this draw-
back and offers greater insight into the endogenous role of
MAGUKs. Acute overexpression or RNAi-mediated knockdown
of PSD-93 or PSD-95 results in correlated changes in the num-
ber of synaptic AMPA-type glutamate receptors (AMPARs),
demonstrating that MAGUKs play an instructive role in the
localization of synaptic AMPARs (Chen et al., 2011; Ehrlich
et al., 2007; Ehrlich and Malinow, 2004; Elias et al., 2006;
Schlu¨ter et al., 2006).
Reductions in PSD-93 or PSD-95 by RNAi-mediated knock-
down cause loss of AMPAR-containing synapses. Strikingly,
there is no deficit in the number of AMPARs at the remaining
synapses, which has been interpreted to mean that individual
synapses may each contain either PSD-93 or PSD-95 (Elias
et al., 2006) or that the MAGUKs may be required primarily
for the development of AMPAR-containing synapses (Ehrlich
et al., 2007). Additionally, removal of several other scaffolding
proteins present at all PSDs, including GKAP (Shin et al.,
2012) and Shank1 (Hung et al., 2008), also results in all-or-
none loss of AMPAR-containing synapses rather than uniform
loss of some AMPARs from every synapse. While these data
might suggest that synapses are highly heterogeneous and
these scaffolding proteins each play a functional role at only
a subset of synapses, a plausible alternative would be that
loss of ubiquitous synaptic proteins from all synapses triggers
a compensatory reorganization in a process resembling a ho-
meostatic rearrangement in an effort to maintain the number
of AMPARs at each synapse. The most obvious candidate
pathway for this reorganization would be the canonical homeo-
static pathway, in which signaling dependent on calcium entry
through L-type voltage-gated calcium channels (LTCCs) (Ibata
et al., 2008; Thiagarajan et al., 2005) acts on downstream
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Figure 1. Pan-MAGUK Knockdown Reduces Synaptic AMPAR and NMDAR-Mediated Currents
(A) CAG hybrid promoter drives EGFP with a synthetic 30 UTR containing miRNA hairpins against PSD-93, PSD-95, and SAP102.
(B) Infection of dissociated hippocampal neurons with lentivirus expressing theMAGUKmiRNA construct results in reductions in the amount of PSD-95, PSD-93,
and SAP102 protein without any change in the loading control actin.
(C) Scatter plots showing reductions in AMPAR and NMDAR EPSCs in MAGUK miRNA-transfected neurons compared to untransfected controls (AMPAR,
20.84% ± 4.03% control, p < 0.005, n = 41; NMDAR, 33.59% ± 8.22% control, p < 0.005, n = 41). Scatter plots of EPSCs show single pairs (open circles). Bar
graphs show mean ratio ± SEM. AMPAR scale bars represent 25 ms, 25 pA; NMDAR scale bars represent 100 ms, 25 pA.
(D) No change in paired-pulse ratio (PPR), defined as second EPSC over first EPSC (Ctrl 1.75 ± 0.07, Expt 1.59 ± 0.06; p > 0.05, n = 17). Scale bars represent
25 pA, 50 ms. See also Figure S1.targets including GluA2 (Gainey et al., 2009; Goold and Nicoll,
2010; but see Altimimi and Stellwagen, 2013).
The data from single-MAGUK manipulations have supported
the hypothesis that MAGUKs function primarily as ‘‘slots’’ for
AMPARs that control their synaptic abundance (Schnell et al.,
2002; Shi et al., 2001). Knockdown of multiple MAGUKs, how-
ever, causes reductions in both AMPAR- and NMDAR-medi-
ated transmission (Elias et al., 2006), suggesting MAGUKs
play a more fundamental role at the synapse: acting as basic
scaffolding molecules localizing both classes of glutamate
receptors. In this study, we have used a chained-miRNA
approach to reduce expression of PSD-93, PSD-95, and
SAP102 using RNAi-mediated knockdown. These results pro-
vide the first direct study of simultaneous knockdown of the
MAGUKs shown to be responsible for synaptic localization of
glutamate receptors. We find that knockdown of the three
MAGUKs causes large decreases in both AMPAR and NMDAR
transmission, with each of the three MAGUKs playing an equal
role. This deficit results purely from a reduction in the number
of synapses containing glutamate receptors without any
decrease in synaptic strength of the remaining functional syn-
apses or spine density. Furthermore, we show that the all-or-
none loss of AMPARs is a result of ‘‘winner-take-all’’ synaptic
consolidation, a process that acts to normalize quantal size.
Remarkably, this process, which has not previously been
described, implies that individual synapses have an intrinsic
set point.RESULTS
Pan-MAGUK Knockdown Reduces Synaptic AMPAR
and NMDAR-Mediated Currents
To test whether the MAGUKs are necessary for glutamatergic
transmission, we created a construct containing the CAG hybrid
promoter driving expression of GFP and chainedmicroRNAs tar-
geting the three synaptic MAGUKs: PSD-93, PSD-95, and
SAP102 (hereafter called the MAGUK miRNA, Figure 1A). The
fourth member of the MAGUK family, SAP97, has been found
not to play a role in baseline transmission (Howard et al., 2010)
and was therefore initially excluded. Previous experiments
exploring the role of the MAGUK family have been unable to
make direct comparisons between neurons lacking MAGUKs
and wild-type cells and have therefore suffered from an inability
to quantify the effects of acute MAGUK removal directly. Viral
infection of the MAGUK miRNA, using sequences that have pre-
viously been validated individually (Elias et al., 2006), substan-
tially reduced protein levels of PSD-93, PSD-95, and SAP102
in dissociated hippocampal neurons (Figure 1B). To determine
the functional consequences of MAGUK knockdown, we per-
formed dual whole-cell recordings in rat hippocampal organo-
typic cultures. We biolistically transfected neurons with the
MAGUK miRNA and identified transfected, GFP-expressing
CA1 pyramidal neurons by morphology and location. We then
stimulated Schaffer collaterals and performed simultaneous
whole-cell recording of evoked excitatory postsynaptic currentsNeuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc. 535
(EPSCs) frompairs of transfected and neighboring untransfected
control neurons. Expression of the MAGUKmiRNA caused large
and equivalent reductions in both AMPAR and NMDAR trans-
mission (Figure 1C), leaving only a small glutamatergic EPSC.
Importantly, viral infection of slice cultures via microinjection fol-
lowed by dual whole-cell recording produced equivalent results
(Figures S1A–S1C), validating our use of viral infection for our
biochemical characterization (Figure 1B). A previous report using
germline knockouts showed the MAGUKs have the ability to
compensate for loss of several family members (Elias et al.,
2006), and our knockdown strategy left open the possibility
that SAP97, though it has no role in baseline function, might
play a compensatory role. To determine whether SAP97 plays
such a role, we transfected slice cultures from SAP97 knockout
mice (Howard et al., 2010). There was no further reduction in
transmission in SAP97 knockout mice compared to wild-type
mice (Figures S1D–S1G), indicating that SAP97 does not play
a compensatory role. We therefore continued the study looking
only at knockdown of PSD-93, PSD-95, and SAP102. Although
our results demonstrate that MAGUKs are responsible for the
large majority of synaptic glutamatergic current, it is difficult to
ascertain the source of the remaining current. It could be due
either to an incomplete removal of MAGUK protein or to a
MAGUK-independent mechanism.
The reduction in both AMPAR andNMDAR transmission could
be explained by changes in the three synaptic parameters: a pre-
synaptic decrease in neurotransmitter release probability (Pr), a
decrease in number of functional synapses (N), or a decrease
in the postsynaptic response to glutamate, here likely due to a
decrease in the number of glutamate receptors at each synapse
(q). Several previous studies have found knockdown of PSD-95
causes solely a postsynaptic effect (Elias et al., 2006; Schlu¨ter
et al., 2006; but see Futai et al., 2007). To determine whether
the removal of all three MAGUKs results in a presynaptic deficit,
we measured the paired-pulse ratio, an indicator of neurotrans-
mitter release probability, and found no change (Figure 1D). This
result indicates that the decrease in fast glutamatergic transmis-
sion cannot be explained by changes in Pr and is due to either a
decrease in the number of functional synapses, a decrease in the
number of receptors per synapse postsynaptically, or a combi-
nation of the two effects.
All MAGUKs Play Roles in Baseline Glutamate Receptor
Localization
Before further characterizing the general role of the MAGUK pro-
tein family, we first wanted to determine the contribution of each
member to baseline fast excitatory transmission. Previous ex-
periments (Elias et al., 2006) have reported that PSD-93 and
PSD-95 each account for half of AMPAR-mediated transmission
(but see Kru¨ger et al., 2013), while SAP102 plays a compensatory
role if both PSD-93 and PSD-95 are lost. Knockdown of PSD-93
or PSD-95 has been reported to have either no (Elias et al., 2006)
or minimal effect (Ehrlich et al., 2007) on NMDAR currents. These
single-knockdown results, combined with our data that the
MAGUK miRNA has a significant effect on NMDAR currents,
indicate that synaptic NMDARs are lost in significant numbers
only whenmultiple MAGUKs are lost. To determine the individual
contribution of each MAGUK family member in our system, we536 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.used miRNA constructs targeting each single MAGUK as
described in Figure 1A, with a CAG promoter driving GFP
followed by miRNA against PSD-93, PSD-95, or SAP102 in its
30 UTR.
We find that knockdown of each MAGUK caused equivalent
decreases in glutamatergic transmission. Removal of PSD-93,
PSD-95, or SAP102 individually caused a decrease of about
50% in AMPAR and 25% in NMDAR transmission (Figures 2A–
2C). Furthermore, the arithmetic addition of individual contribu-
tions of the MAGUKs to baseline AMPAR transmission (50%
per MAGUK member, summing to an impossible 150%) results
in an overestimate of the total contribution (Figure 2D). This sug-
gests that removal of a small number of MAGUKs causes a
disproportionately large reduction in AMPAR currents. Electron
microscopy studies have shown that synapses with PSD diam-
eter < 180 nm do not contain AMPARs and represent ‘‘silent syn-
apses’’ (Takumi et al., 1999), suggesting that although small
PSDs presumably contain MAGUKs, a primary component of
the PSD (Chen et al., 2008; Sheng and Hoogenraad, 2007),
PSDs with few MAGUKs cannot localize AMPARs. Therefore,
as MAGUKs are lost, AMPAR transmission will decrease dispro-
portionately as many small MAGUK-containing synapses fall
under the size threshold required to contain AMPARs (Takumi
et al., 1999).
Incremental removal of MAGUKs results in a small reduction in
NMDAR current that is additive, in contrast to the cooperative ef-
fects on AMPARs, with the triple MAGUK miRNA resulting in a
decrease that is approximately three times as large as any single
miRNA (Figure 2D). These results suggest that the relationship
between MAGUK and NMDAR binding is roughly linear, with de-
creases in MAGUK abundance resulting in equivalent decreases
in NMDAR content at synapses. This is in agreement with elec-
tron microscopy data showing NMDAR content is independent
of PSD size (Takumi et al., 1999), meaning PSD size reductions
do not cause reductions in NMDAR content. It is therefore likely
that NMDAR EPSC reductions reflect loss of NMDAR-containing
synapses. Additionally, we were surprised to find that knock-
down of SAP102, which previously had been thought to be un-
necessary for baseline transmission in organotypic rat slices
(Elias et al., 2006), reduced both AMPAR and NMDAR currents,
demonstrating a role for SAP102 in mediating baseline currents
(Figure 2C).
Dependence of SAP102 Phenotype on Method of RNAi
Delivery
What might account for the difference between our present re-
sults (Figure 2C), in which knockdown of SAP102 reduced
both AMPAR and NMDAR currents, and previous published re-
sults, which found no effect (Elias et al., 2006)? One possible
technical explanation for this disagreement could be the method
of RNAi delivery in organotypic slices. We noticed a striking
pattern in previous experiments: delivery of PSD-95 shRNA via
viral transduction (Elias et al., 2006; Schlu¨ter et al., 2006) did
not decrease NMDAR current, while biolistic transfection of
PSD-95 shRNA constructs (Ehrlich et al., 2007; Futai et al.,
2007) caused a decrease in both AMPAR and NMDAR current.
We reasoned that biolistic transfection might be more effective
at knocking down endogenous protein, and we therefore
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Figure 2. All MAGUKs Play Roles in Baseline Glutamate Receptor Localization
(A) PSD-93 knockdown causes decrease of AMPAR-mediated current (49.23% ± 8.34% control, p < 0.005, n = 17) and NMDAR-mediated current (71.34% ±
11.44% control, p < 0.05, n = 17).
(B) PSD-95 knockdown causes decrease of AMPAR-mediated current (45.38% ± 7.457% control, p < 0.005, n = 34) and NMDAR-mediated current (75.38% ±
11.37% control, p < 0.05, n = 31).
(C) SAP102 knockdown causes decrease of AMPAR-mediated current (54.83% ± 12.45% control, p < 0.05, n = 13) and NMDAR-mediated current (63.74% ±
20.07% control, p < 0.01, n = 11).
(D) Summary graphs of mean ± SEM. EPSC amplitudes, expressed as a percentage of control EPSC values.
Open circles represent amplitudes for single pairs. Scale bars represent 25 pA, 50 ms.explored whether the method of RNAi transfection might ac-
count for the difference.
If viral transduction with our SAP102 RNAi construct causes
no deficit, it would suggest that the phenotype we see is specific
to biolistic transfection and implicate the transfection method as
the critical parameter. Although our biochemical results using
virus in dissociated cultures (Figure 1B) show almost complete
loss of MAGUK protein, we cannot directly extrapolate these
data to slice culture, due to differences in the preparation and
the transduction method, including potential differences in
expression levels of the MAGUKs, differential expression of the
CAG promoter, and differences in multiplicity of infection.
We therefore injected virus carrying our SAP102 knockdown
construct into organotypic slice cultures and performed simulta-
neous whole-cell recordings. We found that, in contrast to the
decrease seen following biolistic transfection, viral knockdown
had no effect on AMPAR currents compared to controls,
although there was a small but significant decrease in NMDAR
current that differed significantly from the decrease seen
following biolistic transfection (Figure 3A). We therefore
conclude that the method of delivery controls the SAP102
phenotype. One possible explanation is the duration of knock-
down; infection with lentivirus may take effect more slowly
than biolistic transfection. One alternate explanation, however,
is the possibility that high miRNA expression levels could revealoff-target effects that were not strong enough to be functionally
relevant at lower expression levels but now cause reductions in
glutamatergic transmission. To determine whether biolistic
transfection of SAP102 RNAi could be having off-target effects,
we tested the SAP102 RNAi in slices from SAP102 germline
knockout mice. Since the SAP102 protein has been genetically
removed from all cells in this experiment, any differences be-
tween transfected and untransfected neurons caused by
SAP102 miRNA transfection must be attributed to off-target ef-
fects on other proteins. As a control, we first confirmed our
RNAi worked as expected in wild-type mice, causing a pheno-
type indistinguishable from that in rat (Figure 3B). In SAP102
knockout mice, we found biolistic transfection of SAP102 RNAi
caused no change in either AMPAR or NMDAR transmission
compared to controls (Figures 3C and 3D). We therefore
conclude that our biolistic SAP102 knockdown phenotype in
rat is due to a more efficient removal of SAP102 protein and
not an off-target effect.
These results demonstrate that the method of RNAi transfec-
tion has important consequences for knockdown phenotypes
and that biolistic transfection of RNAi results in more efficient
removal of MAGUKs than viral transduction. Furthermore, they
indicate that SAP102 contributes to baseline currents, which
had not been previously observed and is now apparent due to
a methodological improvement.Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc. 537
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Figure 3. Dependence of SAP102 Phenotype on Method of RNAi Delivery
(A) SAP102 knockdown by viral transduction does not decrease AMPAR currents (88.95% ± 8.87% control, p > 0.05, n = 16), in contrast to biolistic knockdown
(54.83% ± 12.45% control) (biolistics versus virus p < 0.05, n = 13 biolistics; n = 16 virus). SAP102 knockdown by viral transduction slightly decreases NMDAR
currents (83.03% ± 11.04% control, p < 0.05, n = 15). Biolistic knockdown (63.74% ± 20.07% control) results in a greater decrease of NMDAR currents (biolistics
versus virus p < 0.01, n = 11 biolistics; n = 15 virus).
(B) Biolistic knockdown of SAP102 in wild-type mice causes a decrease of AMPAR-mediated current (52.03% ± 7.06% control, p < 0.01, n = 13). Biolistic
knockdown of SAP102 in wild-type mice causes a decrease of NMDAR-mediated current (65.58% ± 9.49% control, p < 0.05, n = 13).
(C) Biolistic knockdown of SAP102 in SAP102 knockout mice results in no change in AMPAR-mediated currents (102.70% ± 20.06% control, p > 0.05, n = 15) or
NMDAR-mediated currents (90.16% ± 15.22% control, p > 0.05, n = 14).
(D) Knockdown of SAP102 inwild-typemice causes a statistically significant decrease in AMPAR-mediated current compared to knockdown in SAP102 knockout
mice (wild-type versus KO p < 0.05, n = 13WT, n = 15 KO). Knockdown of SAP102 in wild-type mice causes a statistically significant decrease in NMDAR current
compared to controls, but not compared to knockdown in SAP102 knockout mice, although there is a trend toward significance (wild-type versus KO p > 0.05,
n = 13 WT, n = 14 KO).
Open circles represent amplitudes for single pairs. Scale bars represent 25 pA, 50 ms.MAGUK Knockdown Causes Loss of Functional
Glutamatergic Synapses
After finding that PSD-93, PSD-95, and SAP102 all play roles in
baseline transmission, we returned to the initial finding that
knockdown of all three proteins causes large reductions of
both AMPAR and NMDAR-mediated currents (Figure 1C). These
reductions could be due to a reduction in the number of func-
tional synapses (N), a reduction in the number of glutamatergic
receptors present at each synapse (q), or a mixture of the two.
Determination of these quantal parameters requires analysis of
glutamatergic transmission at individual synapses, usually
done by miniature EPSC (mEPSC) analysis. We chose to mea-
sure evoked currents rather than mEPSCs and picked two com-
plementary techniques to split evoked currents into their constit-
uent quantal events. Each technique offered an advantage over
mEPSC analysis: Sr2+-evoked asynchronous EPSCs (aEPSCs)
allowed us to link the quantal responses as closely as possible
to the evoked currents we analyze elsewhere in this study, and
coefficient of variation (CV) analysis allowed us to circumvent
the electrical noise limit inherent in mEPSC recordings, which
prevents observation of synapses containing few AMPARs.538 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.To record aEPSCs, we replaced the Ca2+ normally present in
the extracellular solution with equimolar Sr2+. When Ca2+ is re-
placed with Sr2+, synchronous transmitter release is replaced by
asynchronous release, which lasts for a few hundredmilliseconds
after the stimulus (Miledi, 1966;Oliet et al., 1996;Xu-Friedmanand
Regehr, 2000). These aEPSCs are isolated quantal events. Anal-
ysis of the frequency (Figure 4A) and amplitude (Figure 4B) of
aEPSCs fromsimultaneously recordedneuronsyields information
about quantal content (N * Pr) and quantal size (q), respectively.
aEPSC frequency decreased following MAGUK knockdown (Fig-
ure4C)withnodifference inaverageaEPSCamplitude(Figure4D),
indicating that followingMAGUKknockdown,quantal content has
decreased with no change in quantal size. We additionally found
no irregularities in the shape of the cumulative distribution func-
tions for aEPSC amplitude and inter-event interval (Figures 4E
and 4F), indicating changes are occurring at all synapses. A
decrease in quantal content could be due to either a reduction
in functional synapse number or probability of neurotransmitter
release. Since MAGUK knockdown caused no change in the
paired-pulse ratio (Figure 1D), the decrease in quantal content is
due to a reduction in the number of functional synapses.
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Figure 4. MAGUK Knockdown Causes Loss of Functional Glutamatergic Synapses
(A) Representative sample traces of asynchronous EPSCs (aEPSCs) recorded in the presence of Sr2+ in neurons expressing MAGUK miRNA or control neurons.
50 ms following stimulation (gray box) was excluded from analysis. Scale bars represent 50 ms, 15 pA.
(B) Representative average aEPSC traces showing no change in average amplitude. Black trace is control; green trace is experimental. Scale bars represent
20 ms, 4 pA.
(C) aEPSC frequency in neurons expressing MAGUK miRNA. Plot shows single pairs (open circles) and mean ± SEM (filled circles). aEPSC frequency is
significantly reduced (p < 0.05) in neurons expressing MAGUK miRNA.
(D) aEPSC amplitude in neurons expressing MAGUK miRNA. Plot as in (C). There is no change in amplitude between control and MAGUK miRNA neurons
(p = 0.15, n = 13).
(E and F) Cumulative distribution plots of aEPSC frequency and amplitude. Control shown in black, experimental in green. Cumulative distribution functions show
no irregularities.
(G and H) Coefficient of variation analysis of simultaneously recorded pairs of control/miRNA neurons. CV2 graphed against ratio of mean amplitude within each
pair. Results along the horizontal y = 1 line are consistent with change in quantal size (q), results along gray dashed identity (45) line are consistent with change in
quantal content (N 3 Pr). Analysis of AMPAR and NMDAR responses suggests decrease is due to reduction in quantal content. Small solid and dashed lines
indicate linear regression line and 95% confidence intervals, respectively.
(I) Summary of coefficient of variation analysis. Both AMPAR and NMDAR average fall on the identity line (p < 0.05 versus horizontal line), while average response
after D-APV falls on horizontal y = 1 line (p > 0.05). See also Figure S2.To complement our aEPSC data, we performed CV analysis
on our EPSCs recorded in Ca2+. This method of analysis utilizes
the inherent variability in synaptic responses over many trials,
which is caused by stochastic neurotransmitter release. Bycomparing the normalized variance in responses from two neu-
rons receiving the same stimulus, it is possible to determine rela-
tive quantal size and quantal content. Changes in quantal size
precisely change both the mean EPSC and the variance suchNeuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc. 539
that the normalized ratio of mean2/variance, also known as (co-
efficient of variation)2 or CV2, remains constant. In contrast,
changes in quantal content will cause proportional changes of
equal magnitude in CV2 (Bekkers and Stevens, 1990; Del Cas-
tillo and Katz, 1954; Gray et al., 2011; Malinow and Tsien, 1990;
Marie et al., 2005). To demonstrate this principle in our prepara-
tion, we compared NMDAR EPSCs from control neurons before
and after adding 1 mM D-APV, a sub-saturating concentration
that blocks approximately half of all NMDARs, causing a reduc-
tion of about 50% in NMDAR EPSC (Figure S2A). The effect of
this reduction on the variance can be visualized graphically by
plotting mean EPSC against CV2. Average responses on the
45 line represent equivalent changes in EPSC and CV2 and
therefore pure changes in quantal content, while responses on
the horizontal y = 1 line represent changes in EPSC amplitude
without changes in variance and therefore represent changes
in quantal size. In the case of D-APV, the ratio CV2 is un-
changed, as would be expected from uniform block of 50% of
NMDARs at all synapses causing a reduction in quantal size (Fig-
ure S2B, re-plotted in Figure 4I). Analysis of evoked AMPAR (Fig-
ure 4G) and NMDAR (Figure 4H) currents following MAGUK
knockdown in simultaneously recorded neurons showed equal
reductions in CV2 and mean EPSC (Figure 4I), suggesting that
the decrease in mean EPSC was due to decreased quantal con-
tent, in agreement with our aEPSC data (Figures 4A–4F). We
conclude that MAGUK knockdown results in a decrease in the
number of functional synapses.
One finding that could explain a loss of functional synapses
is a decrease in the number of dendritic spines, the cellular
sites of excitatory synaptic contacts (Harris and Kater, 1994;
Harris and Stevens, 1989). We therefore used confocal micro-
scopy to compare spine density on the primary apical den-
drites of control and MAGUK miRNA-expressing neurons. We
found no difference in spine density between control and trans-
fected neurons, suggesting that the MAGUKs play no role in
spine formation (Figures S2C and S2D). This dissociation of
the normally tight relationship between spines and functional
synapses suggests that excitatory synaptic formation is mech-
anistically a two-step process consisting first of a spinogenic
phase, in which the structural framework for a functional syn-
apse is laid, and a subsequent synaptogenic phase, in which
ionotropic receptors localize to the synapse using a MAGUK-
dependent mechanism. To determine whether MAGUKs might
play a role in spine maintenance and maturation, we character-
ized spine morphology using super-resolution structured illumi-
nation microscopy (SIM). We find that MAGUK knockdown has
no effect on spine neck length or diameter, but does signifi-
cantly reduce spine head diameter (Figures S2E–S2H). Interest-
ingly, this deficit in spine head diameter is mediated by a selec-
tive reduction in the number of spines with large heads, which
presumably fail to mature in the absence of MAGUKs (Figures
S2I and S2J). These results suggest that MAGUK loss curtails
spine maturation. We therefore conclude that spine growth and
maturation must have an initial MAGUK-independent phase
followed by a MAGUK-dependent growth phase, likely an ac-
tivity-dependent process dependent on the presence of a func-
tional synapse. Finally, it has been suggested that the MAGUKs
form complexes with extrasynaptic glutamate receptors (Rao540 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.et al., 1998). To determine whether MAGUKs might have a
functional role in trafficking of glutamate receptors to the
neuronal surface, we recorded whole-cell AMPAR and NMDAR
currents (Figures S2K–S2N). We found no change, suggesting
that the MAGUKs are not necessary for trafficking of glutamate
receptors to the neuronal surface and instead are specifically
necessary for synaptic localization of surface glutamate
receptors.
L-Type Voltage-Gated Calcium Channels Are Required
for Synaptic Consolidation
Loss of the MAGUKs causes reductions in AMPAR and NMDAR
transmission (Figure 1C). The MAGUKs are a critical component
of the PSD likely required for normal AMPAR transmission at all
synapses. One simple prediction following loss of MAGUKs
would therefore be uniform loss of AMPARs from every synapse
resulting in a reduction of quantal size with little change in func-
tional synapse number. Further analysis of the AMPAR trans-
mission reduction, however, has found that it is due primarily
to a reduction in the number of AMPAR-containing synapses
with no change in quantal size (Ehrlich et al., 2007; this work,
Figure 4; Elias et al., 2006). We therefore hypothesized that a
compensatory mechanism must be acting to normalize quantal
size, with the effect of converting the initial uniform removal of
some AMPAR from every synapse into an all-or-none loss of
synapses.
We reasoned that an active compensatory program would
require a sensor of perturbed activity, and began by testing the
involvement of the most well-characterized activity sensor: the
L-type voltage-gated calcium channel (LTCC), a critical sensor
of neuronal activity required for the activity of downstream ho-
meostatic effector molecules. Homeostasis is induced by devia-
tions in LTCC activity. Direct reduction in LTCC signaling via
nifedipine application induces scaling up (Ibata et al., 2008; Thia-
garajan et al., 2005; Wang et al., 2011), and increased excitation
reduces synaptic currents via a mechanism requiring the LTCC
(Goold and Nicoll, 2010). Together, these data indicate that the
LTCC is required bi-directionally to maintain excitatory transmis-
sion. We reasoned that involvement of the LTCC in consolidation
would suggest an active process at work akin to homeostasis
working to maintain quantal size, while intact consolidation in
the absence of LTCC signaling would imply the canonical
homeostatic pathways were not involved. We biolistically trans-
fected neurons with theMAGUKmiRNAwhile blocking the activ-
ity of LTCCs in organotypic slice cultures by addition of nifedi-
pine to the culture media. We found that knockdown of the
MAGUKs in the presence of nifedipine caused large decreases
in AMPAR and NMDAR EPSCs compared to neighboring neu-
rons (Figure 5A). This decrease did not differ significantly from
the reductions caused by the MAGUK miRNA in the absence
of nifedipine (Figures 5B and 5C, dashed line and shaded box
indicate mean ± SEM of miRNA without nifedipine), indicating
that LTCCs are not involved in mediating the effect of MAGUK
knockdown. These results indicate that synaptic consolidation
shifts AMPARs to normalize quantal size without a change in
overall receptor number (model, Figure 7F). Finally, there was
no change in the paired-pulse ratio, indicating that the addition
of nifedipine did not change probability of release (Figure 5D).
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Figure 5. L-Type Calcium Channels Are Required for Synaptic Consolidation
(A) MAGUK miRNA transfection in the presence of 20 mM nifedipine causes significant reductions in both AMPAR and NMDAR EPSCs compared to neighboring
untransfected neurons (AMPAR 20.17% ± 3.24%; NMDAR 21.35% ± 4.17%; n = 10 and p < 0.05 for both).
(B andC) Summary data showing no additional change in AMPAR or NMDAREPSCs inMAGUKmiNRA-expressing neurons with nifedipine compared toMAGUK
miRNA alone (p > 0.05 for both). Dashed line and shaded area show mean ± SEM of normalized synaptic responses for MAGUK miRNA without nifedipine.
(D) No change in paired-pulse ratio (PPR), defined as second EPSC over first EPSC (Ctrl 1.63 ± 0.11, Expt 1.72 ± 0.17; p > 0.05, n = 9).
(E and F) Coefficient of variation analysis of simultaneously recorded pairs of control/miRNA neurons. CV2 graphed against ratio of mean amplitude within each
pair. Results along the horizontal line are consistent with change in quantal size (q), results along identity (45) line are consistent with change in quantal content
(N3 Pr). Decrease in AMPAR EPSC is due to reduction in quantal size. Decrease in NMDAR EPSC is due to reduction in quantal content. Small solid and dashed
lines indicate linear regression line and 95% confidence intervals, respectively.
(G) Summary of coefficient of variation analysis. AMPAR average falls near the horizontal line (p < 0.05 compared to horizontal line) and NMDAR average falls on
the identity line. Data from MAGUK miRNA without nifedipine incubation (Figure 4G) are re-plotted to aid comparison.
(H)Coefficient of variation analysis of simultaneously recordedpairs of control/PSD-95miRNAneurons (black circle) shows the reduction inAMPAREPSC isdue to
reductions inquantal content.Reduction inAMPAREPSC followingPSD-95knockdownandnifedipine incubation (greencircle) is due to reductions inquantal size.
(I and J) Coefficient of variation analysis of simultaneously recorded pairs of control/miRNA neurons either 24 hr (I) or 96 hr (J) after nifedipine washout. Twenty-
four hours after washout, the decrease in AMPAR EPSC is due to reductions in quantal content and quantal size. Ninety-six hours after nifedipine washout, the
decrease in AMPAR EPSC is due to pure reduction in quantal content.
(K) Summary graph showing slope of CV dataset regression line versus hours post-nifedipine washout. As a control, nifedipine was not washed out of some slices
(dashed line and black square). See also Figure S3.
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CV2 analysis demonstrates that in the presence of nifedipine,
the reduction in AMPAR EPSCs caused by MAGUK miRNA is
largely due to a reduction in quantal size (Figure 5E), in contrast
to the reduction in quantal content caused by the MAGUK
miRNA without nifedipine (Figure 4G). A small decrease in
CV2 remains, however, and indicates a small reduction in
quantal content, possibly due to an across-the-board reduction
in AMPAR content converting weak synapses to AMPAR-silent
synapses. CV2 analysis of NMDAR EPSCs shows a reduction
in quantal content (Figure 5F) identical to that seen in the
absence of nifedipine (Figure 4H), meaning that the all-or-none
loss of NMDAR-containing synapses is not reliant on LTCC
signaling. MAGUK miRNA data without nifedipine (Figure 4G)
have been re-plotted to aid in comparison (Figure 5G). These re-
sults suggest that the AMPARs, but not NMDARs, undergo
consolidation dependent on signaling by LTCCs following
MAGUK knockdown.
Previous data showing the all-or-none loss following MAGUK
removal have been collected following knockdown of a single
member of the MAGUK family (Ehrlich et al., 2007; Elias
et al., 2006). We have found knockdown of the entire MAGUK
family leads to consolidation, but to directly determine whether
consolidation acts following the milder disruption caused by
removal of a single MAGUK family member, we knocked
down PSD-95 in the presence of nifedipine. We find that knock-
down of only PSD-95 causes consolidation, which is blocked
by incubation in nifedipine, demonstrating that loss of a single
MAGUK family member is sufficient to trigger consolidation
(Figure 5H).
Since addition of nifedipine to the slice culture media affects
both the transfected and neighboring neurons, we wanted to
test whether consolidation could be rescued in a cell-autono-
mous manner. Our CV2 analysis reports differences between
transfected and control neurons and could be influenced by
nifedipine acting on these controls. To confirm that LTCCs
were acting to effect consolidation in the transfected neuron,
we made use of cell-autonomous rescue with the nifedipine-
insensitive T1036Y LTCC mutant (Dolmetsch et al., 2001; He
et al., 1997), hereafter referred to as T1036Y. If LTCCs in the
transfected neuron underlie consolidation, block of consolida-
tion by nifedipine should be rescued by expression of T1036Y.
We first confirmed surface expression of T1036Y by simulta-
neously measuring calcium currents in neurons biolistically
transfected with T1036Y and neighboring untransfected neurons
(Figure S3A), finding a large nifedipine-insensitive increase in
current in neurons expressing T1036Y (Figures S3B–S3D).
Expression of T1036Y with the MAGUK miRNA in the absence
of nifedipine did not modulate the reduction in quantal content
caused by MAGUK knockdown (Figure S3E). Co-expression of
T1036Y and MAGUK miRNA in the presence of nifedipine
rescued synaptic consolidation and resulted in a reduction in
AMPAR quantal content (Figures S3F and S3G). In all cases,
there was no change in the magnitude of amplitude reduction
in either AMPAR or NMDAR transmission compared to the
MAGUK miRNA alone (Figures S3H–S3J), indicating that under
these circumstances, nifedipine has no differential effect on syn-
aptic transmission. These data also suggest that overexpression
of CaV1.2 has no effect on synaptic transmission, in line with pre-542 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.vious results (Wang et al., 2011), perhaps due to rate-limiting
quantities of a downstream protein in the pathway.
Together, these results indicate that signaling pathways trig-
gered by calcium flux through LTCCs are necessary for synaptic
consolidation following knockdown of the MAGUKs. The
involvement of LTCCs strongly suggests a two-step process
by which MAGUK knockdown causes a reduction in quantal
size, followed by a compensatory process resulting in a normal-
ization of quantal size and reduction in quantal content. Further-
more, the manipulation of a signaling pathway via pharmacology
without any additional structural perturbation indicates reorgani-
zation is an active, regulated process rather than a structural
consequence of MAGUK protein loss.
Direct Electrophysiological Observation
of Consolidation
Although incubation of miRNA-transfected slice cultures in
nifedipine allowed us to infer that synaptic consolidation via
L-type signaling must occur, we next attempted to strengthen
this finding by directly observing neurons undergoing consolida-
tion. We hypothesized that consolidation would occur on the
same timescale asmultiplicative synaptic scaling, a well-charac-
terized form of homeostasis dependent on L-type signaling,
which can induce homeostatic changes in less than 24 hr (Ibata
et al., 2008; Turrigiano et al., 1998). As previous studies have
shown the half-life of PSD-95 is approximately 36 hr (El-Husseini
et al., 2002), recordingwithin a few days of transfection, aswould
be required if consolidation happened on the same timescale as
synaptic scaling, would not allow sufficient time for degradation
of the existing protein. Instead, we took advantage of the finding
that nifedipine blocks consolidation and incubated organotypic
slices in nifedipine for 6 days, as done to test the involvement
of LTCCs (Figures 5A–5H), which allows time for MAGUK protein
degradation while blocking consolidation. Following 6 days in
nifedipine, during which consolidation was blocked, slices
were removed from nifedipine and recordings were done to
assess the degree of consolidation on each subsequent day.
We found consolidation to be a linear process resulting in
complete consolidation by 4 days following nifedipine washout
(Figures 5I–5K; intermediate time points in Figures S3K and
S3L). We additionally recorded from slices incubated in nifedi-
pine with no washout to determine whether some consolidation
might occur during this longer incubation despite the presence
of nifedipine. We found no consolidation occurred in the pres-
ence of nifedipine (Figure S3M). These experiments establish a
time course for consolidation. Although we are unable to mea-
sure consolidation that occurs directly after MAGUK knock-
down, we infer that it relies on the same mechanism and occurs
with the same kinetics. Additionally, these experiments demon-
strate that consolidation can occur long after the loss of
MAGUKs, further dissociating it from the initial EPSC reduction
and showing that it is a separate compensatory process.
CaM Kinase Kinase Is Required for Consolidation
of Synapses
We next attempted to identify targets of signaling through LTCC
during consolidation. Previous work has determined that protein
synthesis is necessary for certain forms of homeostatic plasticity
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Figure 6. CaMKinase Kinase Is Required for
Synaptic Consolidation
(A) Coefficient of variation analysis of simulta-
neously recorded pairs of control/miRNA neurons
in slices incubated with 3 mM STO-609. The
decrease in AMPAR EPSCs is due to reduction in
quantal size and quantal content. Small solid and
dashed lines indicate linear regression line and
95% confidence intervals, respectively.
(B) Summary of coefficient of variation analysis.
Data from MAGUK miRNA alone (Figure 4G), and
plus nifedipine incubation (Figure 5E), are re-
plotted to aid comparison.
(C) Coefficient of variation analysis of simulta-
neously recorded pairs of control/miRNA +CaMKK
L233F neurons in slices incubated in STO-609. The
decrease in AMPAR EPSC is due to reduction in
quantal content.
(D) Summary of coefficient of variation analysis.
Data from MAGUK miRNA alone (Figure 4G), and
plus nifedipine incubation (Figure 5E), are re-
plotted to aid comparison.
(E) MAGUK miRNA transfected in the presence of
3 mM STO-609 causes reductions in both AMPAR
and NMDAR EPSC (AMPAR 31.93% ± 6.66%, n =
12; NMDAR 46.98.1% ± 13.14%, n = 12; p < 0.05
for both).
(F) MAGUK miRNA co-transfected with STO-609
insensitive CaMKK L233F in the presence of
STO-609 causes reductions in both AMPAR and
NMDAR EPSC (AMPAR 22.31% ± 4.32%, n = 9;
NMDAR 22.86% ± 3.14%, n = 6; p < 0.05 for both).
(G) Summary data showing no additional change in
AMPAR EPSC reduction due to incubation in STO-
609 and co-expression of CaMKK L233F (p > 0.05
for all).and has specifically identified CaM Kinase 4 (CaMK4) as a tran-
scriptional regulator that plays a role downstream of the LTCC
(Goold and Nicoll, 2010; Ibata et al., 2008). Additionally, the rela-
tively long period required for full consolidation suggests
changes in protein synthesis may be required. The upstreamNeuron 87, 534–5CaMK4 regulator CaMKK (Soderling,
1999; Wayman et al., 2008) is an attractive
target for testing whether CaMK4-medi-
ated transcriptional regulation is neces-
sary for consolidation, since both pharma-
cological inhibition and cell-autonomous
rescue of inhibition via a drug-insensitive
recombinant protein are possible. Inhibi-
tion of CaMKK by STO-609 (Tokumitsu
et al., 2002) in slices transfected with the
MAGUK miRNA hampered consolidation,
resulting in a reduction in quantal size (Fig-
ures 6A and 6B). This deficit in consolida-
tionwas rescued by expression ofCaMKK
L233F, which is insensitive to STO-609
(Tokumitsu et al., 2003). Co-expression
of MAGUK miRNA and CaMKK L233F
in the presence of STO-609 resulted
in consolidation indistinguishable fromMAGUKmiRNA alone, indicating that the deficit in consolidation
is due to block of CaMKK signaling in the transfected neuron
rather than a non-cell-autonomous result of incubation in STO-
609 (Figures 6C and 6D). In agreement with previous work,
CaMKK has no role in maintaining baseline transmission (Goold48, August 5, 2015 ª2015 Elsevier Inc. 543
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Figure 7. GluA2 AMPAR Subunit Is Required for Synaptic Consolidation
(A and B) Coefficient of variation analysis of simultaneously recorded pairs of control/miRNA neurons in GluA2/ slices. The decrease in AMPAR EPSC is due to
reduction in quantal size and quantal content (p < 0.01 compared to horizontal line). The decrease in NMDAR EPSC is due to reduction in quantal content.
(C) Summary of coefficient of variation analysis. Data from MAGUK miRNA (Figure 4G) are re-plotted to aid comparison.
(D and E) Sr2+-evoked aEPSC amplitude and frequency are reduced in neurons from GluA2/ slices shot with MAGUK miRNA compared to neighboring
GluA2/ neurons (p < 0.05).
(F) Model of synaptic consolidation. MAGUK loss initially causes reductions in number of AMPARs present at individual synapses. Over time, compensatory
processes normalize the number of AMPARs present at the few remaining synapses, at the cost of complete loss of other synapses. The glutamate receptors lost
from synapses are re-distributed on the plasma membrane at extrasynaptic sites and have been omitted for clarity. The total number of surface-localized re-
ceptors remains unchanged. See also Figure S4.and Nicoll, 2010). Critically, incubation with STO-609, with or
without co-expression of CaMKK L233F, had no effect on the
reduction in AMPAR and NMDAR EPSCs caused by MAGUK
knockdown (Figures 6E–6G).
These results indicate that signaling through the LTCC acti-
vates CaMKK. CaMK4, the major downstream target of CaMKK,
plays a role in transcriptional regulation, most notably through
the transcription factor CREB (Bito et al., 1997). We therefore
conclude that, in agreement with the previously described role
for CaMKK (Goold and Nicoll, 2010; Ibata et al., 2008), calcium
influx through LTCCs leads to consolidation via changes in pro-
tein synthesis in a CaMKK/CaMK4-dependent manner. It is not
possible, however, to directly test the necessity of translation
in our system due to the relatively long time required for consol-
idation to occur.
GluA2 Is Required for Consolidation of Synapses
following MAGUK Knockdown
The GluA2 AMPAR subunit has previously been implicated as an
effector molecule in the homeostatic response to perturbations544 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.in cell activity levels (Gainey et al., 2009; Goold and Nicoll,
2010; but see Altimimi and Stellwagen, 2013), which in hippo-
campal neurons is expressed as a modulation of both quantal
content and quantal size (Goold and Nicoll, 2010; Thiagarajan
et al., 2002). It is therefore a promising candidate for involvement
in quantal size re-normalization. To test whether the GluA2 sub-
unit is involved, we knocked down the MAGUKs in organotypic
slice cultures from GluA2 knockout animals (Jia et al., 1996)
and assessed whether loss of GluA2 blocked the putative ho-
meostatic consolidation of synapses. We would expect block
of synapse consolidation to be expressed as a decrease in
quantal size relative to control neurons. We found that CV anal-
ysis (Figures 7A–7C) and analysis of Sr2+-evoked aEPSCs (Fig-
ures 7D and 7E) both revealed a decrease in quantal size. As
seen with LTCC block, a small decrease in quantal content
remains (p < 0.05). Much of the observed reduction in aEPSC fre-
quency (Figure 7D) is likely due to low-amplitude aEPSCs occur-
ring below the noise threshold. In contrast, MAGUK knockdown
in neurons from wild-type organotypic rat cultures causes no
decrease in quantal size as measured by aEPSCs (Figures 4C
and 4D) or CV analysis (Figures 4G–4I). Importantly, the relative
decrease in EPSC amplitude is unchanged (Figure S4) compared
to that seen in wild-type organotypic mouse cultures. We there-
fore conclude that synaptic consolidation uses machinery from
the well-characterized homeostatic pathways, and the GluA2
AMPAR subunit is necessary for synaptic consolidation following
MAGUK knockdown.
DISCUSSION
Wefind that theMAGUK family is of paramount importance in the
localization of both AMPARs and NMDARs at excitatory gluta-
matergic synapses, as is demonstrated by the loss of most glu-
tamatergic current following knockdown of PSD-93, PSD-95,
and SAP102. We used a combination of approaches to charac-
terize the role of MAGUKs in excitatory transmission. Analysis of
spine density and surface glutamatergic currents indicate a spe-
cific role for MAGUKs in synaptic glutamate receptor localization
separate from spine formation or receptor surface trafficking.
Further characterization of the knockdown of all three MAGUKs
reveals that the deficit in glutamatergic current is mediated by a
postsynaptic reduction in the number of functional synapses.We
go on to show that this reduction in synapse number is caused
by a compensatory consolidation of synapses following MAGUK
loss by a mechanism dependent on LTCCs, CaMKK, and GluA2,
implicating a homeostasis-like pathway. Notably, the consolida-
tion does not result in multiplicative synaptic scaling, demon-
strating that the canonical homeostatic pathway likely plays
additional roles. These findings extend previous work by demon-
strating that MAGUKs, in addition to their previously reported
role acting as ‘‘slots’’ for AMPARs, are a core component of
the PSD with an equal role in regulating both types of glutamate
receptors. Furthermore, we describe a compensatory pathway
that utilizes the canonical homeostatic pathway and functions
to oppose deviations in quantal size. This process implies that in-
dividual synapses have an intrinsic set point.
The Role of MAGUKs at the Postsynaptic Density
Our results suggest the MAGUKs play a specific functional role:
localizing glutamate receptors to the PSD. We find no deficit in
either surface spine density (Figures S2C and S2D) or receptor
trafficking (Figures S2K–S2N), in agreement with previous results
(Elias et al., 2008; but see Ehrlich et al., 2007). TheMAGUK family
has been suggested to act as a ‘‘slot protein’’ for AMPARs at the
PSD, controlling the number of AMPARs present at synapses.
This role, however, which has been characterized by single-
MAGUK knockdown, does not preclude additional functions,
and electron microscopy data showing that loss of PSD-95
causes disruption of the electron-dense PSD (Chen et al.,
2008) suggest that beyond localizing synaptic glutamate recep-
tors, MAGUKs are also responsible for localization of scaffolding
and signaling proteins in the PSD. Furthermore, the initial
biochemical characterization of MAGUK function found a direct
interaction with NMDARs, not AMPARs (Kornau et al., 1995).
Here, we find that knockdown of the three MAGUK family mem-
bers together causes approximately an 80% reduction in both
AMPAR and NMDAR synaptic responses (Figure 1C). Although
it is tempting to speculate that the remaining current is mediatedbyMAGUKs that have not been removed, it is worth noting that a
previous study using a combination of knockout mice and RNAi-
mediated knockdown to removeMAGUKs found a quantitatively
similar reduction in AMPAR currents (Elias et al., 2006), opening
the possibility that the remaining receptors may not require
MAGUKs for localization.
The Role of MAGUKs in Synaptogenesis
One unresolved question in the study of synaptic development is
the role and assembly order of proteins at the nascent synapse.
Another group (Ehrlich et al., 2007) has found that knockdown of
PSD-95 causes a loss of NMDAR current and a decrease in spine
density, which they interpret as a role for MAGUKs in the initial
formation of spines. In our hands, however, we find no decrease
in spine density, suggesting that the MAGUKs do not play a role
in the initial formation of spines, but are critical for filling the PSD
with glutamate receptors. While the reasons for the differing re-
sults are unclear, several key differences in experimental
approach exist. We believe that knockdown of the entire MA-
GUK family and observation of the resulting phenotype at a
time point at which protein has been maximally removed pro-
vides the best chance for accurate assessment of the role of
the MAGUK family. Our data demonstrate that synaptogenesis
is mechanistically a two-step process, with an initial spinogenic
step controlled by structural proteins such as neuroligin, whose
loss causes a decrease in spine density (Chih et al., 2005;
Shipman et al., 2011), and a second synaptogenic step depen-
dent onMAGUKs that fills the spine with proteins that are neces-
sary for a functional synapse. As we have not removed SAP97
during our anatomical experiments, however, we cannot rule
out a role for SAP97 in spine formation but not synaptogenesis.
One implication of this hypothesis is that spinogenic proteins
cannot fully depend on MAGUKs for their localization. Proteins
like Kalirin-7, which are thought to interact with PDZ-containing
proteins and have been implicated in spine formation (Penzes
et al., 2001), must have alternate mechanisms of localizing to
the nascent spine. Furthermore, in agreement with previous re-
sults from mice lacking glutamate receptors (Lu et al., 2013),
our data demonstrate that dendritic spines are maintained
despite lacking functional glutamatergic synapses. Interestingly,
we see a decrease in large-diameter spine heads with no
decrease in quantal size.We speculate that these large-diameter
spines may represent spines containing multiple PSDs, and their
reduction reflects loss of an entire PSD, whichwould be reflected
physiologically as a decrease in synapse number.
Synaptic Consolidation following MAGUK Loss
The decrease in quantal size following MAGUK knockdown in
the GluA2 knockout and in slices treated with nifedipine or
STO-609 suggests that the all-or-none synapse loss seen in un-
treated slices is the result of a two-step process: a loss of
AMPARs from all functional synapses resulting in a quantal
size decrease, followed by a compensatory consolidation of syn-
apses, which increases quantal size back to baseline. Consoli-
dation has the effect of preventing changes in quantal size and
may be active throughout the life of the organism. Indeed,
quantal size does not increase measurably over the life of the or-
ganism (Hsia et al., 1998), despite developmental increases inNeuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc. 545
the amount of available synaptic scaffolding proteins (Sans et al.,
2000). Rather, quantal content increases with quantal size held
constant, a phenomenon comparable to the consolidation
observed in this study.
Consolidation requires LTCC activity, while nifedipine-
induced scaling is induced by its absence. We believe this differ-
ence underlies the two separate effects of their shared pathway:
consolidation maintains quantal size, while nifedipine-induced
scaling increases it (Thiagarajan et al., 2005). Consolidation uti-
lizes intact LTCC signaling, which maintains quantal size at
baseline levels, to counteract the reduction in quantal size and
bring synapses back to baseline quantal size. In contrast, nifed-
ipine-induced scaling increases quantal size by disrupting the
LTCC-dependent signal that maintains quantal size. Further-
more, MAGUK knockdown reduces the scaffolding proteins
available before consolidation. This reduction means only a sub-
set of synapses can be scaled up. Returning this subset to base-
line quantal size comes at the cost of complete functional loss of
other synapses, likely as scaffolding proteins consolidate at the
‘‘winning’’ synapses. While it is not clear what factors determine
the winning synapses, only a subset of synapses maintain
NMDARs (Figure 5G). Perhaps NMDAR-containing synapses
would be favored in this competition.
How is consolidation maintained as an all-or-none effect? We
propose that an active signal delivered via tonic LTCC activity to
consolidated synapses maintains baseline quantal size and pre-
vents loss of AMPARs to ‘‘losing,’’ functionally empty synapses
to ‘‘scale up.’’ It cannot be that empty synapses lack the capacity
to add glutamate receptors in this context, since neurons intro-
duced to nifedipine after consolidation has occurred lose the
tonic LTCC signal and no longermaintain consolidated synapses
(Figures S3N and S3O). Therefore, active LTCC signaling main-
tains the ‘‘winner’’ of winner-take-all consolidation. In the
absence of LTCC activity, no winner is generated or maintained
and no imbalance in quantal size appears. Instead, AMPARs are
distributed evenly and all synapses have relatively equal,
reduced quantal sizes.
Wehave found that LTCCs, CaMKK, and theGluA2 subunit are
required for consolidation, in linewith previous evidence that they
are required for homeostatic plasticity. The previously identified
roles of the LTCC andCaMKK in transcription leave two possibil-
ities for the role of GluA2. Either GluA2-containing receptors are
an essential co-regulator, with LTCCs, of CaMKK-dependent
transcription, or GluA2-containing receptors themselves are
selectively modulated during the execution of homeostasis. In
either case, proteins that selectively bind to GluA2, but not
GluA1, such as GRIP, PICK1, and NSF (Bredt and Nicoll, 2003;
Song and Huganir, 2002), are likely to underlie the selective reli-
ance on GluA2, either by transducing a synaptic signal or by
acting to change the abundance of GluA2 at the synapse.
Notably, the consolidation of synapses changes only the distri-
bution of synaptic AMPARs, not their absolute number, as
opposed tomultiplicative synaptic scaling,whichcauses anover-
all increase in the absolute number of synaptic AMPARs in
response to decreased activity. This process is therefore closely
related but distinct from multiplicative synaptic scaling. The
longer duration required for consolidation, 96 hr versus 24 hr for
multiplicative scaling, further differentiates it. Indeed, although546 Neuron 87, 534–548, August 5, 2015 ª2015 Elsevier Inc.previous work (Sun and Turrigiano, 2011) has found activity-
dependent synaptic scaling to be dependent on MAGUKs, they
observeanall-or-none lossof synapses followingMAGUKknock-
down, suggesting that, in agreement with our findings, the three
synaptic MAGUKs are not necessary for synapse consolidation.
The difference between synaptic consolidation and homeostasis
suggests that in MAGUK-knockdown neurons, the machinery for
determining ‘‘default’’ quantal size is intact even though the ability
to change that set point via multiplicative scaling has been abol-
ished. Following nifedipine washout, synapses in MAGUK
miRNA-transfected neurons precisely return their quantal size
to that of control neurons despite the overall decrease in excit-
atory input. This implies that synapses may function as autono-
mous homeostatic elements independent of neuronal-level
homeostasis. While many lines of evidence show neuronal-level
homeostasis in response to changes in firing rate, the mecha-
nisms of synapse-level homeostasis are still being explored (re-
viewed in Lee et al., 2014). The canonical homeostatic pathway,
best-studied in the context of neuron-levelmanipulations, is likely
responsible for activating an array of related processes beyond
neuron-level multiplicative scaling in response to activity pertur-
bation. For example, the GluA2 subunit is necessary for proper
distance-dependent scaling, a process which sets ‘‘default’’
quantal size, likely in a synapse-specific manner, and is an
example of non-multiplicative scaling (Shipman et al., 2013).
These results clarify our understanding of the MAGUK family
and reveal a compensatory pathway that activates in response
to reductions in available MAGUK scaffolding protein. We
demonstrate here the feasibility of knockdown of a protein family
by simultaneously removing PSD-93, PSD-95, and SAP102.
Given the ability of the MAGUKs to heterodimerize (Kim et al.,
1996), we have created a reagent in the MAGUK miRNA that,
when combined with overexpression of recombinant protein,
provides the opportunity to perform detailed structure-function
analyses of individual MAGUK family members on a background
lacking endogenousMAGUKs.We additionally show a role for all
threeMAGUKs inmediating baseline transmission and show that
a consolidation pathway locally normalizes synaptic strength
while causing complete loss of a subset of functional synapses.
Further exploration of this pathway will improve our understand-
ing of the regulation of synaptic strength and may give insight
into the remarkable finding that synaptic strength remains con-
stant throughout development, even as synapse number and
protein abundance change dramatically. Finally, these results
imply that individual synapses autonomously maintain synaptic
strength at an intrinsic set point.EXPERIMENTAL PROCEDURES
Experimental Constructs
The triple MAGUK miRNA construct targeting PSD-93, PSD-95, and SAP102
was made using sequences that have been previously characterized (Elias
et al., 2006). For calcium channel experiments, T1036Y mutation was made
from human CaV1.2 cDNA (gift from D. Julius). See Supplemental Experi-
mental Procedures for details.
Electrophysiology in Slice Cultures
Organotypic hippocampal slice cultures were made as described in Schnell
et al., 2002. Slices from P6-P8 rats were biolistically transfected at 1–2 DIV
(days in vitro). Where specified, viral infections were performed via microinjec-
tion into the CA1 region using a Nanoject (Drummond Scientific) under manual
control. Nifedipine (20 mM) or STO-609 (3 mM) was added at time of trans-
fection. Recordings were performed at DIV 7–9 unless otherwise noted.
Recordings and data analysis were performed as described in Supplemental
Experimental Procedures.
Immunoblotting
Rat primary hippocampal dissociated neurons (E18.5) were infected with lenti-
virus expressing MAGUK miRNA construct or GFP alone at DIV 4–7. Neurons
were harvested at DIV 17–18 in Tris-buffered saline (25 mM Tris [pH 7.4],
150 mM NaCl) plus 0.5% Triton-X and protease inhibitor mix (Roche Applied
Sciences, cOmplete Protease Inhibitor Cocktail Tablets). Cell lysates were
incubated at 4 for 30 min and centrifuged for 15 min at 12,000 g. Proteins
were resolved by SDS-PAGE and analyzed by western blot with antibodies
against PSD-93 (0.4 mg/ml, Neuromab cloneN18/30), PSD-95 (1 mg/ml, Neuro-
mab K28/43), SAP102 (2 mg/ml, Neuromab N19/2), and actin (0.2 mg/ml, Milli-
pore C4).
Lentivirus Production
Three T-75 flasks of rapidly dividing HEK293T cells (ATCC) were transfected
with 27 mg FUGW-MAGUK miRNA or FUGW, plus helper plasmids pVSV-G
(18 mg) and psPAX2 (27 mg) using FuGENE HD (Promega). DNA was incubated
with 210 ml FuGENE HD in 4.5 ml Opti-MEM (Life Technologies) before
transfection, according to the manufacturer’s directions. Forty hours later,
supernatant was collected, filtered, and concentrated using the PEG-it Virus
Precipitation Solution (System Biosciences) according to the manufacturer’s
directions. The resulting pellet was resuspended in 400 ml Opti-MEM or
PBS, flash-frozen, and stored at 80C.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.neuron.2015.07.015.
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